Innovative Treatment Modalities: search for a cure: Gene therapy & other treatments
Promising leads from biology-based studies are encouraged to begin the critical path to clinical translation. Examples include immunotherapy, delivery technologies, gene therapy, new drug development/testing, and new approaches to clinical decision-making
Related Topics
| 6th Symposium on the Intraductal Approach to Breast Cancer | 2009 (Cycle 15) | |||
| Dr. Susan Love Research Foundation | $25,000 | |||
| Award Type: Joining Forces | ||||
| Antibody-based Targeting of Breast Cancer Stem Cells | 2009 (Cycle 15) | |||
| University of California, Santa Barbara | $150,000 | |||
| Award Type: IDEA | ||||
| Modulation of Breast Cancer Stem Cell Response to Radiation | 2009 (Cycle 15) | |||
| University of California, Los Angeles | $250,000 | |||
| Award Type: IDEA-competitive renewal | ||||
| Reducing Surgical Morbidity of Breast Cancer Staging | 2009 (Cycle 15) | |||
| University of California, Davis | $149,983 | |||
| Award Type: IDEA | ||||
| Survival in de novo and Recurrent Metastatic Breast Cancer | 2009 (Cycle 15) | |||
| Beckman Research Institute of the City of Hope | $249,000 | |||
| Award Type: IDEA | ||||
| Metabolite Imaging to Identify Drug Resistant Breast Cancer | 2009 (Cycle 15) | |||
| Lawrence Berkeley National Laboratory | $172,237 | |||
| Award Type: IDEA | ||||
| Breast Cancer Treatment Monitoring Combining MRI and Optics | 2007 (Cycle 13) | |||
| University of California, San Francisco | $149,527 | |||
| Award Type: IDEA | ||||
| Modulation of Breast Cancer Stem Cell Response to Radiation | 2007 (Cycle 13) | |||
| University of California, Los Angeles | $149,500 | |||
| Award Type: IDEA | ||||
| Neural Stem Cell Therapy for Breast Cancer Brain Metastases | 2007 (Cycle 13) | |||
| Scripps Research Institute | $419,400 | |||
| Award Type: IDEA-competitive renewal | ||||
| Intraductal Therapy of DCIS: A Presurgery Study | 2007 (Cycle 13) | |||
| Dr. Susan Love Research Foundation | $851,559 | |||
| Award Type: Translational Research | ||||
| Real-Time 3D Ultrasound Image-Guidance for Breast Surgery | 2006 (Cycle 12) | |||
| Stanford University | $66,141 | |||
| Award Type: Dissertation | ||||
| Intraoperative Assessment of Surgical Lumpectomy Margins | 2006 (Cycle 12) | |||
| John Wayne Cancer Institute | $280,637 | |||
| Award Type: IDEA | ||||
| Neural Stem Cell Therapy for Breast Cancer Brain Metastases | 2006 (Cycle 12) | |||
| Scripps Research Institute | $302,085 | |||
| Award Type: IDEA | ||||
| ID4: a Prognostic Factor of Breast Cancer Metastasis | 2005 (Cycle 11) | |||
| John Wayne Cancer Institute | $283,200 | |||
| Award Type: IDEA | ||||
| Preclinical Trials for Breast Cancer | 2003 (Cycle IX) | |||
| University of California, Davis | $25,000 | |||
| Award Type: Joining Forces | ||||
| Drug Dose Tailoring Based on Patient-Specific Factors | 2002 (Cycle VIII) | |||
| University of California, San Francisco | $11,827 | |||
| Award Type: Dissertation | ||||
| Selective Targeting of Breast Cancer with Radioiodide | 2001 (Cycle VII) | |||
| Stanford University | $315,200 | |||
| Award Type: STEP | ||||
| Herba Scutellaria Barbatae for Metastatic Breast Cancer | 2001 (Cycle VII) | |||
| University of California, San Francisco | $232,364 | |||
| Award Type: STEP | ||||
| Stress Protein and Drug Resistance in Human Breast Cancer | 2000 (Cycle VI) | |||
| University of Southern California | $325,873 | |||
| Award Type: IDEAS II | ||||
| Wnt Signaling in Breast Cancer: Translational Studies | 2000 (Cycle VI) | |||
| University of California, Irvine | $328,129 | |||
| Award Type: TRC Full | ||||
| Chinese Herbal Therapy (CHT) for Symptom Management | 2000 (Cycle VI) | |||
| University of California, San Francisco | $200,000 | |||
| Award Type: IDEAS II | ||||
| Thrombosis for Anti-angiogenic Therapy of Breast Cancer | 2000 (Cycle VI) | |||
| University of California, Irvine | $199,633 | |||
| Award Type: IDEAS II | ||||
| Can Molecular Markers Predict Response to Adjuvant Therapy | 1999 (Cycle V) | |||
| Kaiser Foundation Research Institute | $260,545 | |||
| Award Type: TRC Full | ||||
| Mechanism of Radiosensitivity in Breast Cancer Cells | 1999 (Cycle V) | |||
| Scripps Research Institute | $37,200 | |||
| Award Type: Postdoctoral Fellowship | ||||
| New Radiation Therapy for HER-2-overexpressing Breast Cancer | 1999 (Cycle V) | |||
| University of California, Los Angeles | $200,000 | |||
| Award Type: IDEAS II | ||||
| Breast Cancer Gene Expression Using Amplified Core Biopsies | 1999 (Cycle V) | |||
| Stanford University | $155,286 | |||
| Award Type: IDEAS II | ||||
| Bispecific Antibodies for Radiotherapy of Breast Cancer | 1999 (Cycle V) | |||
| University of California, Davis | $68,615 | |||
| Award Type: Postdoctoral Fellowship | ||||
| Molecular Mapping of Surgical Margins | 1998 (Cycle IV) | |||
| California Pacific Medical Center Research Institute | $287,992 | |||
| Award Type: ITaMoCAs | ||||
| Breast Tumor Markers and Response to Adjuvant Therapy | 1998 (Cycle IV) | |||
| Kaiser Foundation Research Institute | $77,327 | |||
| Award Type: TRC Pilot | ||||
| Timing of Breast Cancer Surgery, Menstrual Cycle & Prognosis | 1998 (Cycle IV) | |||
| University of California, San Diego | $506,070 | |||
| Award Type: TRC Full | ||||
| Breast Cancer Markers and Response to Adjuvant Therapy | 1998 (Cycle IV) | |||
| Kaiser Foundation Research Institute | $0 | |||
| Award Type: TRC Pilot | ||||
| Breast Tumor Markers and Response to Adjuvant Therapy | 1998 (Cycle IV) | |||
| Kaiser Foundation Research Institute | $0 | |||
| Award Type: TRC Pilot | ||||
| Gene Therapy for Breast Cancer | 1997 (Cycle III) | |||
| California Pacific Medical Center Research Institute | $293,383 | |||
| Award Type: ITaMoCAs | ||||
| Inhibition of Angiogenesis in Breast Cancer | 1997 (Cycle III) | |||
| University of California, San Francisco | $67,830 | |||
| Award Type: TRC Pilot | ||||
| The Role of Meltrin-a in Breast Cancer-Associated Bone Loss | 1997 (Cycle III) | |||
| The Burnham Institute for Medical Research | $75,600 | |||
| Award Type: Postdoctoral Fellowship | ||||
| Breast Cancer Gene Therapy Using a Metastasis Inhibitor | 1997 (Cycle III) | |||
| University of Southern California | $75,599 | |||
| Award Type: Postdoctoral Fellowship | ||||
| Improved delivery of pharmaceuticals to breast cancer | 1996 (Cycle II) | |||
| University of California, San Francisco | $145,492 | |||
| Award Type: ITaMoCAs | ||||
| Pre-clinical cryosurgery testing in breast cancer treatment | 1996 (Cycle II) | |||
| University of California, Berkeley | $200,000 | |||
| Award Type: ITaMoCAs | ||||
| Outpatient Stem Cell Transplants for Breast Cancer | 1996 (Cycle II) | |||
| University of California, San Diego | $189,970 | |||
| Award Type: ITaMoCAs | ||||
| Tibetan Medicine for Advanced Breast Cancer | 1996 (Cycle II) | |||
| University of California, San Francisco | $53,231 | |||
| Award Type: ITaMoCAs | ||||
| Radiosurgery of early breast cancer | 1996 (Cycle II) | |||
| University of Southern California | $76,713 | |||
| Award Type: ITaMoCAs | ||||
| Targeted gene therapy using anti-pl85HER2 immunoliposomes | 1996 (Cycle II) | |||
| University of California, San Francisco | $205,410 | |||
| Award Type: ITaMoCAs | ||||
| Outpatient Stem Cell Transplants for Breast Cancer | 1996 (Cycle II) | |||
| Scripps Clinic & Research Foundation | $0 | |||
| Award Type: ITaMoCAs | ||||
| Blocking Breast Cancer Progression with Radioactive Antibody | 1995 (Cycle I) | |||
| University of California, Irvine | $50,000 | |||
| Award Type: IDEA | ||||
| Breast Cancer Chemotherapy: Does It Impair Brain Function? | 1995 (Cycle I) | |||
| California School of Professional Psychology | $307,456 | |||
| Award Type: New Investigator | ||||
| Investigation of Improved Drug Delivery in Breast Cancer | 1995 (Cycle I) | |||
| University of California, Irvine | $292,905 | |||
| Award Type: Research Project | ||||
